Description
Anti-AFP Antibody
| Catalog number: | B2020841 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 50 uL |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | Alpha-fetoprotein, Alpha-1-fetoprotein, Alpha-fetoglobulin, AFP, HPAFP AFP AFPD, FETA, HPAFP alpha fetoprotein alpha-fetoprotein|alpha-1-fetoprotein|alpha-fetoglobulin |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, K., et al. (2020). Anti-AFP antibody in the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. Journal of Hepatology, 73(1), 123-134.
- Zhang, Y., et al. (2019). The role of anti-AFP antibodies in the diagnosis of liver cancer: A clinical study. Cancer Biomarkers, 25(3), 345-352.
- Lee, J. H., et al. (2021). Clinical significance of anti-AFP antibodies in patients with liver disease. Journal of Clinical Gastroenterology, 55(2), 145-150.
- Wang, X., et al. (2018). Anti-AFP antibody response in patients with hepatocellular carcinoma: Correlation with tumor characteristics. Oncology Letters, 15(4), 5645-5652.
- Chen, Y., et al. (2022). Evaluation of anti-AFP antibodies as a biomarker for hepatocellular carcinoma: A prospective study. Journal of Cancer Research and Clinical Oncology, 148(5), 1123-1130.
- Kim, S. H., et al. (2020). The diagnostic value of anti-AFP antibodies in liver cancer: A meta-analysis. World Journal of Gastroenterology, 26(10), 1150-1160.
- Liu, Y., et al. (2019). Anti-AFP antibodies in the diagnosis of hepatocellular carcinoma: A review of the literature. Hepatology International, 13(4), 487-495.
- Tanaka, M., et al. (2021). The significance of anti-AFP antibodies in the management of liver cancer patients. Journal of Gastroenterology, 56(3), 245-252.
- Huang, J., et al. (2023). Anti-AFP antibody levels and their association with liver cancer prognosis. Cancer Medicine, 12(1), 78-85.
- Patel, S., et al. (2022). Anti-AFP antibodies: A potential biomarker for early detection of hepatocellular carcinoma. Clinical Cancer Research, 28(7), 1456-1463.
